Are your kidneys OK? detect early to protect kidney health
DOI:
https://doi.org/10.52786/isu.a.104Keywords:
Screening, case finding, chronic kidney disease, albuminuria, proteinuria, preventionAbstract
Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day we assert that case-finding in high-risk populations, or even population level screening, can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic, simple to test for and recent paradigm shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, healthcare funding, healthcare infrastructure and healthcare-professional and population awareness of kidney disease. Coordinated efforts by major kidney non-governmental organizations to prioritise the kidney health agenda for governments and aligning early detection efforts with other current programs will maximise efficiencies.
References
Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) Syndrome: a scientific statement from the American Heart Association. Circulation 2023;148:1636-64.
Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, et al. Mind the gap in kidney care: translating what we know into what we do. Kidney Int 2024;105:406-17.
Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024;105:S117-314.
Guha C, Lopez-Vargas P, Ju A, Gutman T, Scholes-Robertson NJ, Baumgart A, et al. Patient needs and priorities for patient navigator pro- grammes in chronic kidney disease: a workshop report. BMJ Open 2020;10:e040617.
Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990- 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020;395:709-33.
Cojuc-Konigsberg G, Guijosa A, Moscona-Nissan A, Nordmann-Gomes A, Canaviri-Flores VA, Braverman-Poyastro A, et al. Representation of low- and middle-income countries in CKD drug trials: a systematic review. Am J Kidney Dis 2024;85:55-66.e1.
Hsiao LL, Shah KM, Liew A, Abdellatif D, Balducci A, Haris A, et al. Kidney health for all: preparedness for the unexpected in supporting the vulnerable. Kidney Int 2023;103:436-43.
Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol 2024;20:473-85.
Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 2018;392:2052-90.
Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol 2020;16:452- 69.
Chen K, Didsbury M, van Zwieten A, Howell M, Kim S, Tong A, et al. Neurocognitive and educational outcomes in children and adolescents with CKD: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2018;13:387-397.
Francis A, Didsbury MS, van Zwieten A, Chen K, James LJ, Kim S, et al. Quality of life of children and adolescents with chronic kidney disease: a cross-sectional study. Arch Dis Child 2019;104:134-40.
United States Renal Data System [Internet]. 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. [cited 2025 Jan 1]. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2023. Available from: https://us- rds-adr.niddk.nih.gov/2023
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015;385:1975-82.
Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al. Assessment of Global Kidney Health Care Status. JAMA 2017;317:1864-81.
Ortiz A, Wanner C, Gansevoort R. Chronic kidney disease as cardiovascular risk factor in routine clin- ical practice: a position statement by the Council of the European Renal Association. Nephrol Dial Transplant 2023;38:527-31.
Johnson RJ, Wesseling C, Newman LS. Chronic kidney disease of unknown cause in agricultural communities. New Engl J Med 2019;380:1843-52.
McCulloch M, Luyckx VA, Cullis B, Davies SJ, Finkelstein FO, Yap HK, et al. Challenges of access to kidney care for children in low-resource settings. Nat Rev Nephrol 2021;17:33-45.
Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and middle-income coun- tries. Nephrol Dial Transplant 2016;31:868-74.
Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W, et al. Comprehensive public health strategies for preventing the devel- opment, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis 2009;53:522-35.
Nephrology ISo [Internet]. [cited 2025 Jan 1]. World Kidney Day 2025. Available from: https://www. worldkidneyday.org/about-kidney-health/
Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, et al. Life’s essential 8: updating and enhancing the American Heart Association’s Construct of Cardiovascular Health: a presidential advisory from the american heart association. Circulation 2022;146:e18-43.
Bello AK, Okpechi IG, Levin A, Ye F, Damster S, Arruebo S, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health 2024;12:e382-95.
Ferre S, Storfer-Isser A, Kinderknecht K, Montgomery E, Godwin M, Andrews A, et al. Fulfillment and validity of the kidney health evaluation measure for people with diabetes. Mayo Clin Proc Innov Qual Outcomes 2023;7:382-91.
Alfego D, Ennis J, Gillespie B, Lewis MJ, Mont- gomery E, Ferre S, et al. Chronic kidney disease testing among at-risk adults in the U.S. remains low: real-world evidence from a national laboratory database. Diabetes Care 2021;44:2025-32.
Stempniewicz N, Vassalotti JA, Cuddeback JK, Ciemins E, Storfer-Isser A, Sang Y, et al. Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. Health Care Organizations. Diabetes Care 2021;44:2000-9.
Kushner PR, DeMeis J, Stevens P, Gjurovic AM, Malvolti E, Tangri N. Patient and clinician perspec- tives: to create a better future for chronic kidney disease, we need to talk about our kidneys. Adv Ther 2024;41:1318-24.
Farrell DR, Vassalotti JA. Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? BMC Nephrol 2024;25:34.
Tuttle KR. CKD screening for better kidney health: Why? Who? How? When? Nephrol Dial Transplant 2024;39:1537-9.
Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al. The case for early identifi- cation and intervention of chronic kidney disease:conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2021;99:34-47.
Tummalapalli SL, Shlipak MG, Damster S, Jha V, Malik C, Levin A, et al. Availability and affordability of kidney health laboratory tests around the globe. Am J Nephrol 2020;51:959-65.
Seegmiller JC, Bachmann LM. Urine albumin measurements in clinical diagnostics. Clin Chem 2024;70:382-91.
van Mil D, Kieneker LM, Heerspink HJL, Gansevoort RT. Screening for chronic kidney disease: change of perspective and novel developments. Curr Opin Nephrol Hypertens 2024;33:583-92.
Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Lernmark A, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2023;69:808-68.
Tonelli M, Dickinson JA. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries. J Am Soc Nephrol 2020;31:1931-40.
Moreno JA, Martin-Cleary C, Gutierrez E, Ru- bio-Navarro A, Ortiz A, Praga M, et al. Haematuria: the forgotten CKD factor? Nephrol Dial Transplant 2012;27:28-34.
Franceschini N, Feldman DL, Berg JS, Besse W, Chang AR, Dahl NK, et al. Advancing genetic testing in kidney diseases: report from a National Kidney Foundation Working Group. Am J Kidney Dis 2024;84:751-66.
Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, et al. Long-term risks for kidney donors. Kidney Inter 2014;86:162-7.
Francis A, Abdul Hafidz MI, Ekrikpo UE, Chen T, Wijewickrama E, Tannor EK, et al. Barriers to accessing essential medicines for kidney disease in low- and lower middle-income countries. Kidney Int 2022;102:969-73.
Baigent C, Emberson J, Haynes R, Herrington WG, Judge P, Landray MJ, et al. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet 2022;400:1788-801.
Vart P, Vaduganathan M, Jongs N, Remuzzi G, Wheeler DC, Hou FF, et al. Estimated lifetime benefit of combined RAAS and SGLT2 inhibitor therapy in patients with albuminuric CKD without diabetes. Clin J Am Soc Nephrol 2022;17:1754-62.
Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 2017; 13:393-409.
Berman-Parks N, Berman-Parks I, Gómez-Ruíz IA, Ardavin-Ituarte JM, Piccoli GB. Combining patient care and environmental protection: a pilot pro- gram recycling polyvinyl chloride from automated peritoneal dialysis waste. Kidney Inter Rep 2024;9: 1908-11.
Essue BM, Laba M, Knaul F, Chu A, Minh HV, Nguyen TKP, et al. Economic burden of chronic ill health and injuries for households in low- and middle-income countries. In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, et al., editors. Disease control priorities: improving health and reducing poverty. Washington (DC): The International Bank for Reconstruction and Development / The World Bank© 2018 International Bank for Reconstruction and Development / The World Bank.; 2017:Chapter 6.
Yeo SC, Wang H, Ang YG, Lim CK, Ooi XY. Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review. Clin Kidney J 2024;17:sfad137.
Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD. Population-wide screening for chronic kidney disease : a cost-effectiveness analysis. Ann Intern Med 2023;176:788-97.
Yadla M, John P, Fong VK, Anandh U. Ethical issues related to early screening programs in low resource settings. Kidney Inter Rep 2024;9:2315-9.
Szczech LA, Stewart RC, Su HL, DeLoskey RJ, Astor BC, Fox CH, et al. Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease). PLoS One 2014;9:e110535.
Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD, et al. Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med 2016;129:153-62. e7.
Thavarajah S, Knicely DH, Choi MJ. CKD for pri- mary care practitioners: Can we cut to the chase without too many shortcuts? Am J Kidney Dis 2016;67:826-9.
Vassalotti JA, Boucree SC. Integrating CKD into US Primary Care: bridging the knowledge and implementation gaps. Kidney Int Rep 2022;7:389-96.
Luyckx VA, Moosa MR. Priority setting as an ethical imperative in managing global dialysis access and improving kidney care. Semin Nephrol 2021;41:230-41.
CDC [Internet]. [cited Jan 1]. Chronic Kidney Disease in the United States 2023. Available from: https://www.cdc.gov/kidneydisease/publica- tions-resources/CKD-national-facts.html
Ritchie H. Does the news reflect what we die from? 2019 [Internet]. [cited 2022 Sept 8]. Available from: https://ourworldindata.org/does-the-news-reflect- what-we-die-from
Boulware LE, Carson KA, Troll MU, Powe NR, Coo- per LA. Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. J Gen Intern Med 2009;24:1123-9.
Foundation NK [Internet]. [cited 2025 Jan 1]. Kidney Quiz 2024. Available from: https://www.kidney.org/kidney-quiz/
Tuot DS, Crowley ST, Katz LA, Leung J, Alcantara-Cadillo DK, Ruser C, et al. Usability Testing of the Kidney Score Platform to Enhance Commu- nication About Kidney Disease in Primary Care Settings: Qualitative Think-Aloud Study. JMIR Form Res 2022;6:e40001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Insight Urology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
